These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15270615)

  • 1. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
    Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
    Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
    Dacic S; Finkelstein SD; Yousem SA
    Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung.
    Sartori G; Bettelli S; Schirosi L; Bigiani N; Maiorana A; Cavazza A; Rossi G
    Am J Surg Pathol; 2007 Oct; 31(10):1512-20. PubMed ID: 17895751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma.
    Sasatomi E; Johnson LR; Aldeeb DN; Lomago DM; Thompson JW; Swalsky PA; Luketich JD; Fernando HC; Finkelstein SD; Yousem SA
    Am J Surg Pathol; 2004 Oct; 28(10):1280-8. PubMed ID: 15371943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma.
    Lee HJ; Jang SJ; Chun SM; Park SI; Kim DK; Choi J
    Exp Lung Res; 2011 Aug; 37(6):344-53. PubMed ID: 21649526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
    Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
    J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic analysis of pulmonary Langerhans cell histiocytosis.
    Dacic S; Trusky C; Bakker A; Finkelstein SD; Yousem SA
    Hum Pathol; 2003 Dec; 34(12):1345-9. PubMed ID: 14691922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping.
    Dacic S; Finkelstein SD; Sasatomi E; Swalsky PA; Yousem SA
    Am J Surg Pathol; 2002 Apr; 26(4):510-6. PubMed ID: 11914631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
    Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
    Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
    Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung.
    Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K
    Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
    Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
    Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
    Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value.
    Sasatomi E; Finkelstein SD; Woods JD; Bakker A; Swalsky PA; Luketich JD; Fernando HC; Yousem SA
    Cancer Res; 2002 May; 62(9):2681-9. PubMed ID: 11980668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
    Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
    Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of allelic loss of synchronous adenocarcinomas of the lung.
    Dacic S; Ionescu DN; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Jul; 29(7):897-902. PubMed ID: 15958854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases.
    Sheikh HA; Sasatomi E; Finkelstein S; Yousem SA
    Am J Surg Pathol; 2005 Oct; 29(10):1267-73. PubMed ID: 16160467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.